These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release. Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221 [TBL] [Abstract][Full Text] [Related]
13. [ Action mechanisms of modern antidepressives]. Müller WE Pharm Unserer Zeit; 2004; 33(4):288-95. PubMed ID: 15287689 [No Abstract] [Full Text] [Related]
14. New antidepressant medications. Wynn RL Gen Dent; 1997; 45(1):24-8. PubMed ID: 9171475 [No Abstract] [Full Text] [Related]
15. Benefits and harms of pediatric antidepressant medications. Waslick B JAMA; 2007 Aug; 298(6):626; author reply 627. PubMed ID: 17684184 [No Abstract] [Full Text] [Related]
16. Venlafaxine: not yet first in the antidepressant class. Harv Ment Health Lett; 2003 Apr; 19(10):5-7. PubMed ID: 12711568 [No Abstract] [Full Text] [Related]
17. Prognostic effects of selective serotonin reuptake inhibitors in patients with coronary artery bypass grafting. Wei L; Chen R Am J Cardiol; 2006 Dec; 98(12):1667. PubMed ID: 17145233 [No Abstract] [Full Text] [Related]